Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RS

Rita Steeves — 13 Patents

IMImmunogen: 7 patents #24 of 119Top 25%
APAcceleron Pharma: 5 patents #13 of 55Top 25%
BHBrigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
THThe Bringham And Women'S Hospital: 1 patents #1 of 30Top 4%
Johnson & Johnson: 1 patents #4,783 of 7,810Top 65%
Stoneham, MA: #25 of 278 inventorsTop 9%
Massachusetts: #9,700 of 88,656 inventorsTop 15%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Rita Steeves has been granted 13 US patents while listed as an inventor at Immunogen. The first was granted in 2011 and the most recent in April 2024. Rita Steeves ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Rita Steeves in Stoneham, MA, US.

Patents per Year

Patents granted per year, 2011 to 2024Bar chart with a peak of 4 patents in 2012.peak 42011: 1 patents20112012: 4 patents20122013: 2 patents20132017: 1 patents20172019: 1 patents20192020: 1 patents20202021: 2 patents20212024: 1 patents2024

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11951156 Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor Paul B. Yu, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Ravindra Kumar 2024-04-09
11008377 Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptides Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2021-05-18 $70,636,000
10981973 Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptide Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2021-04-20 $36,217,000
10682392 Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion protein Paul B. Yu, Asya Grinberg, Dianne Sako, Roselyne Castonguay, Ravindra Kumar 2020-06-16
10316076 Transforming growth factor-beta receptor type II fusion polypeptides Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2019-06-11 $27,502,000
9809637 Transforming growth factor beta receptor II fusion polypeptides Ravindra Kumar, Asya Grinberg, Dianne Sako, Roselyne Castonguay 2017-11-07
8603483 Anti-integrin immunoconjugates, methods and uses Qiming Chen, Mohit Trikha, Robert J. Lutz, Godfrey Amphlett 2013-12-10
8388960 Elimination of heterogeneous or mixed cell population in tumors Viktor S. Goldmakher, Robert J. Lutz, Ravi V. J. Chari, Yelena Kovtun, John M. Lambert +2 more 2013-03-05 $12,092,000
8198417 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2012-06-12 $11,159,000
8163888 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2012-04-24 $9,326,000
8137669 Elimination of heterogeneous or mixed cell population in tumors Viktor S. Goldmakher, Robert J. Lutz, Ravi V. J. Chari, Yelena Kovtun, John M. Lambert +1 more 2012-03-20 $12,722,000
8088387 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2012-01-03 $9,904,000
7989598 Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates Ravi V. J. Chari, Walter A. Blattler 2011-08-02 $13,325,000